This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (107)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Roger C. Cornell, MD; Richard B. Stoughton, MD

Arch Dermatol. 1985;121(1):63-67.

Abstract
• A large group of glucocorticosteroid formulations were assayed by the vasoconstriction test in normal skin sites and paired comparison studies in patients with psoriasis. Excellent correlation between the vasoconstriction assay and selected paired comparison studies occurred in 20 of 23 instances. In three instances, involving two glucocorticosteroid formulations tested, correlation was absent. The vasoconstrictor assay is an inexpensive and reliable method for screening glucocorticosteroid formulations for clinical activity in psoriasis.

(Arch Dermatol 1985;121:63-67)

Author Affiliations
From the Division of Dermatology, Scripps Clinic and Research Foundation, La Jolla, Calif (Dr Cornell); and the Department of Dermatology, School of Medicine, University of California, San Diego (Dr Stoughton).

Footnotes
Accepted for publication May 29, 1984.

Reprint requests to Division of Dermatology, Scripps Clinic and Research Foundation, 10666 N Torrey Pines Rd, La Jolla, CA 92037 (Dr Cornell).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Psoriasis treatment: traditional therapy
Lebwohl et al.
Ann Rheum Dis 2005;64:ii83-ii86.
ABSTRACT | FULL TEXT  

Transient Effect of Inhaled Fluticasone on Airway Mucosal Blood Flow in Subjects with and without Asthma
KUMAR et al.
Am. J. Respir. Crit. Care Med. 2000;161:918-921.
ABSTRACT | FULL TEXT  

A Transgenic Mouse Model Provides a Novel Biological Assay of Topical Glucocorticosteroid Potency
Katchman et al.
Arch Dermatol 1995;131:1274-1278.
ABSTRACT  

Topical 0.050% Betamethasone Dipropionate: Pharmacokinetic and Pharmacodynamic Dose-Response Studies in Humans
Pershing et al.
Arch Dermatol 1994;130:740-747.
ABSTRACT  

A Double-blind Controlled Comparison of Generic and Trade-Name Topical Steroids Using the Vasoconstriction Assay
Olsen
Arch Dermatol 1991;127:197-201.
ABSTRACT  

Intrinsic Potencies of Novel Thiol Ester Corticosteroids RS-85095 and RS-21314 as Compared With Clobetasol 17-Propionate and Fluocinonide
Ong et al.
Arch Dermatol 1989;125:1662-1665.
ABSTRACT  

The Same Glucocorticoid in Brand-Name Products: Does Increasing the Concentration Result in Greater Topical Biologic Activity?
Stoughton and Wullich
Arch Dermatol 1989;125:1509-1511.
ABSTRACT  

`Vasoconstriction'--Skin Blanching--Assay for Glucocorticoids--a Critique
Shah et al.
Arch Dermatol 1989;125:1558-1561.
ABSTRACT  

Assessment of Disease Progress in Psoriasis
Marks et al.
Arch Dermatol 1989;125:235-240.
ABSTRACT  

Anthralin-Corticosteroid Combination Therapy in the Treatment of Chronic Plaque Psoriasis
Monk et al.
Arch Dermatol 1988;124:548-550.
ABSTRACT  

Are Generic Formulations Equivalent to Trade Name Topical Glucocorticoids?
Stoughton
Arch Dermatol 1987;123:1312-1314.
ABSTRACT  

Correlation of the Vasoconstrictor Assay and Clinical Activity in Psoriasis
Woodford and Barry
Arch Dermatol 1986;122:1355-1355.
ABSTRACT  

Correlation of the Vasoconstrictor Assay and Clinical Activity in Psoriasis
Gibson
Arch Dermatol 1985;121:1105-1105.
ABSTRACT